Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers

Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers

Objectives: This phase III study assessed the safety and immunogenicity of MenACWY-CRM, a quadrivalent meningococcal conjugate vaccine, administered with routine vaccines starting at 2 months of age. Methods: Healthy infants received MenACWY-CRM in a two- or three-dose primary infant series plus a s...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Miguel Tregnaghi, Pio Lopez, Daniel Stamboulian, Gabriela Graña, Tatjana Odrljin, Lisa Bedell, Peter M. Dull
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Elsevier 2014-09-01
Sarja:International Journal of Infectious Diseases
Aiheet:
Meningitis
Meningococcal vaccines
Conjugate vaccines
Treatment efficacy
Safety
Linkit:http://www.sciencedirect.com/science/article/pii/S1201971214014842

Internet

http://www.sciencedirect.com/science/article/pii/S1201971214014842

Samankaltaisia teoksia